Harry Reyes Nieva

Harry Reyes Nieva

Auto-generated profile, based on publicly available information

Harry Reyes Nieva

Department of Medicine, Division of Infectious Diseases, Columbia University

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2014 in JAMA Internal Medicine
Verified
Journal Article
Open access
PDF file
JLJeffrey A Linder
Jeffrey A Linder
JDJason N. Doctor
Jason N. Doctor
MFMark W. Friedberg
Mark W. Friedberg
HNHarry Reyes Nieva
Harry Reyes Nieva
CBCaroline Birks
Caroline Birks
CFCraig R. Fox
Craig R. Fox
Clinicians make many patient care decisions each day. The cumulative cognitive demand of these decisions may erode clinicians’ abilities to resist making potentially inappropriate choices. Psychologists, who refer to the erosion of self-control after making repeated decisions as decision fatigue,1,2 have found evidence that it affects nonmedical professionals. For example, as court sessions wear on, judges are more likely to deny parole, the “easier” or “safer” option.3

1 January 2015 in International Journal of Medical Informatics
Verified
Journal Article
Closed access
BCBeth Chaplin
Beth Chaplin
SMSeema Meloni
Seema Meloni
GEGeoffrey Eisen
Geoffrey Eisen
TJToyin Jolayemi
Toyin Jolayemi
BBBolanle Banigbe
Bolanle Banigbe
PKPhyllis Jean Kanki
Phyllis Jean Kanki

26 May 2022 in JAMIA Open
Verified
Journal Article
Open access
PDF file
OWOliver J Bear Don’t Walk
Oliver J Bear Don’t Walk
HNHarry Reyes Nieva
Harry Reyes Nieva
SLSandra Soo-Jin Lee
Sandra Soo-Jin Lee
NENoémie Elhadad
Noémie Elhadad
The objective of this work is to explore the ethical considerations of clinical natural language processing (NLP) in the context of bias. Bias here refers to systematic differences in terms of representation or application of NLP models between group identities like race, gender, and sexuality. We searched PubMed and Google Scholar for articles concerning NLP, ethics, and bias between 2015 and 2021. We analyzed articles against a framework that combines different stages of the machine learning (ML) development process (design, data, algorithm, critique) and important ethical principles in the medical domain. We included 22 out of 1162 prescreened articles in this review. Articles were categorized into: design (N = 2), data (N = 12), algorithm (N = 14), and critique (N = 17). Clinical NLP can be used to study bias in research that relies on clinical text as well as explore biases in the healthcare setting. We identify 3 areas of active research at the intersection of clinical NLP and ethics: (1) selecting performance metrics that interrogate bias in ML; (2) opportunities and risks of identifying sensitive patient information like gender, and sexuality; and (3) best practices in balancing individual autonomy, leveraging patient data, and inferring and manipulating sensitive information of subgroups.

29 April 2021 in BMJ Quality & Safety
Verified
Journal Article
Closed access
PDF file
JSJeffrey L Schnipper
Jeffrey L Schnipper
HNHarry Reyes Nieva
Harry Reyes Nieva
MMMeghan Mallouk
Meghan Mallouk
AMAmanda Mixon
Amanda Mixon
SRStephanie Rennke
Stephanie Rennke
SKSunil Kripalani
Sunil Kripalani
Background The first Multicenter Medication Reconciliation Quality Improvement (QI) Study (MARQUIS1) demonstrated that mentored implementation of a medication reconciliation best practices toolkit decreased total unintentional medication discrepancies in five hospitals, but results varied by site. The objective of this study was to determine the effects of a refined toolkit on a larger group of hospitals. Methods We conducted a pragmatic quality improvement study (MARQUIS2) at 18 North American hospitals or hospital systems from 2016 to 2018. Incorporating lessons learnt from MARQUIS1, we implemented a refined toolkit, offering 17 system-level and 6 patient-level interventions. One of eight physician mentors coached each site via monthly calls and performed one to two site visits. The primary outcome was number of unintentional medication discrepancies in admission or discharge orders per patient. Time series analysis used multivariable Poisson regression. Results A total of 4947 patients were sampled, including 1229 patients preimplementation and 3718 patients postimplementation. Both the number of system-level interventions adopted per site and the proportion of patients receiving patient-level interventions increased over time. During the intervention, patients experienced a steady decline in their medication discrepancy rate from 2.85 discrepancies per patient to 0.98 discrepancies per patient. An interrupted time series analysis of the 17 sites with sufficient data for analysis showed the intervention was associated with a 5% relative decrease in discrepancies per month over baseline temporal trends (adjusted incidence rate ratio: 0.95, 95% CI 0.93 to 0.97, p<0.001). Receipt of patient-level interventions was associated with decreased discrepancy rates, and these associations increased over time as sites adopted more system-level interventions. Conclusion A multicentre medication reconciliation QI initiative using mentored implementation of a refined best practices toolkit, including patient-level and system-level interventions, was associated with a substantial decrease in unintentional medication discrepancies over time. Future efforts should focus on sustainability and spread.

20 November 2020 in BMJ Open Respiratory Research
Verified
Journal Article
Open access
PDF file
GYGloria Y. Yeh
Gloria Y. Yeh
DLDaniel Litrownik
Daniel Litrownik
PWPeter M. Wayne
Peter M. Wayne
DBDouglas Beach
Douglas Beach
EKElizabeth S. Klings
Elizabeth S. Klings
MMMarilyn L. Moy
Marilyn L. Moy
Background Despite therapeutic advances, the management of chronic obstructive pulmonary disease (COPD) remains complex. There is growing interest in multidimensional, mind-body exercises to improve both physical and psychosocial aspects of COPD burden. Few US data are available in this population on tai chi (TC) a mind-body exercise incorporating physical activity, breathing and mindful awareness. We explored feasibility and preliminary efficacy of TC in COPD in an US academic medical setting. Methods Patients with COPD Global Obstructive Lung Disease (GOLD) stages 2–4 were randomised to a 12-week TC programme or education control. At 12 weeks, those in TC were randomised again to continue in maintenance classes or not to further explore optimal duration. All groups were followed to 24 weeks. Feasibility/safety parameters were analysed descriptively. Preliminary between-group differences were estimated in symptoms (dyspnoea, fatigue), health-related quality-of-life (Chronic Respiratory Questionnaire CRQ), cognitive-emotional measures (mood, COPD self-efficacy) and functional status (6 min walk test, lower body strength, flexibility, physical activity). Results Ninety-two subjects were randomised (N=61 TC, N=31 education). Mean age was 68±8 years, 66% male, mean forced expiratory volume in 1 s % predicted 57±13, 28% were GOLD stage 3–4. Overall retention was 85%. Nineteen adverse events occurred, most being study-unrelated COPD exacerbations. From baseline to 12 weeks, there were between-group improvements favouring TC, in CRQ-total (Cohen’s d effect size (ES)=0.46; adj mean diff (AMD)=0.31), CRQ-emotion (ES=0.54; AMD=0.49), Centre for Epidemiologic Studies Depression (ES=−0.37; AMD=2.39) and Patient-Reported Outcome Measurement Information System (PROMIS)-fatigue (ES=−0.34; AMD=−0.17). From baseline to 24 weeks, there was an improvement favouring TC in CRQ-dyspnoea (ES=0.41; AMD=0.46). Among TC participants, there was a positive effect of maintenance classes on self-efficacy (ES=−0.69; AMD=−0.40), 6 min walk (ES=0.56; AMD=49.26 feet), PROMIS-fatigue (ES=−0.41; AMD=−0.28) and chair stand (0.43; AMD=0.56). Conclusion TC in patients with COPD is feasible and safe. Preliminary analyses support a potential modest role in improving quality-of-life, cognitive-emotional health and function that should be further studied. Trial registration number NCT01551953. IRB reference BIDMC 2010P-000412; VA 2540.

11 September 2019 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
AMAmanda S. Mixon
Amanda S. Mixon
GJG. Randy Smith Jr
G. Randy Smith Jr
MMMeghan Mallouk
Meghan Mallouk
HNHarry Reyes Nieva
Harry Reyes Nieva
SKSunil Kripalani
Sunil Kripalani
JSJeffrey L. Schnipper
Jeffrey L. Schnipper
Background: The first Multi-center Medication Reconciliation Quality Improvement Study (MARQUIS1) demonstrated that implementation of a medication reconciliation best practices toolkit decreased total unintentional medication discrepancies in five hospitals. We sought to implement the MARQUIS toolkit in more diverse hospitals, incorporating lessons learned from MARQUIS1.Methods: MARQUIS2 is a pragmatic, mentored implementation QI study which collected clinical and implementation outcomes. Sites implemented a revised toolkit, which included interventions from these domains: 1) best possible medication history (BPMH)-taking; 2) discharge medication reconciliation and patient/caregiver counseling; 3) identifying and defining clinician roles and responsibilities; 4) risk stratification; 5) health information technology improvements; 6) improved access to medication sources; 7) identification and correction of real-time discrepancies; and, 8) stakeholder engagement. Eight hospitalists mentored the sites via one site visit and monthly phone calls over the 18-month intervention period. Each site’s local QI team assessed opportunities to improve, implemented at least one of the 17 toolkit components, and accessed a variety of resources (e.g. implementation manual, webinars, and workshops). Outcomes to be assessed will include unintentional medication discrepancies per patient.Discussion: A mentored multi-center medication reconciliation QI initiative using a best practices toolkit was successfully implemented across 18 medical centers. The 18 participating sites varied in size, teaching status, location, and electronic health record (EHR) platform.We introduce barriers to implementation and lessons learned from MARQUIS1, such as the importance of utilizing dedicated, trained medication history takers, simple EHR solutions, clarifying roles and responsibilities, and the input of patients and families when improving medication reconciliation.